Xalkori (crizotinib) 250 mg capsules, 60 capsules — original (Pfizer) Treatment of locally advanced or metastatic non-small cell lung cancer Targeted cancer therapy. Drug delivery from Europe within 4-5 days +380996042415

Price upon request

Indications

• Xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer who have abnormal expression of the anaplastic lymphoma kinase (ALK) gene. PS
• 1890kb